Plans: 105%-108% after 1 day, 56%-59% daily for 2 days, 150% after 5 days.
Min deposit: $1
Max deposit: $∞
Referral: 1%
X
This project is a scam and stopped paying on Oct 13, 2010.
«Medicineprofit» [medicineprofit.com] Summary
The «RiskRank» metric serves as a comprehensive indicator of the overall quality of the «Medicineprofit», evaluated based on multiple criteria. Below is a detailed analysis of medicineprofit.com, with a score ranging from 0 to 10 points.
Green flags:
Excellent hosting: Very few sites on this IP guarantee superior response times and reliable access;
Join using Google, Telegram, Facebook, Twitter account or e-mail!
Content
#Tags
Here's what it says on the medicineprofit.com website:
Nanomedicine is the medical application of nanotechnology. Nanomedicine, ranging from medical applications of nanomaterials, nanoelectronics, to biosensors, and even possible future applications of molecular nanotechnology.
Nanomedicine research is funded by the U.S. National Institutes of Health. Also, investment and development interests of the company and team of professional investors. Are being developed over 200 projects nanotechnology medicine throughout the world
Our fund offers to join the investment in a very profitable and long-term direction of technology
.
respected medical group profitsworldour fund offersprojects nanotechnology medicinemedical applicationmedical applicationsnational institutesdevelopment interestsprofessional investorsmolecular nanotechnologyfuture applicationsterm directionnanomedicine researchnanotechnologynanomedicine
DISCLAIMER: Please note that we do not promote or recommend any programs/projects/games listed here.
Your use of this web site is at your own risk. The materials presented on this site may not reflect the most current legal developments, verdicts or settlements, or the correct law of the jurisdiction in which you reside. All information available on or accessed through this site, is provided "as is." These materials may be changed, improved, or updated without notice.